AUS
NZ
UK
CA
USA
IND
Health
Is Chemed (NYSE:CHE) Ready For A Valuation Rebound?
June 19, 2026 08:10 AM PDT| By Anmol KhazanchiChemed's valuation debate centers on DCF upside, recent share weakness, healthcare demand, and cash flow durability across its core service businesses.
Is ResMed (NYSE:RMD) Market Reset Creating New Interest?
June 19, 2026 07:02 AM PDT| By Anmol KhazanchiSleep health, respiratory care, and digital healthcare innovation continue driving interest in treatment-focused companies operating within a growing and increasingly connected healthcare ecosystem.
Why Are Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO) Driving S&P 500 Healthcare Focus?
June 18, 2026 11:10 PM PDT| By Anmol KhazanchiObesity therapies from Eli Lilly and Novo Nordisk shape healthcare trends within the S&P 500 Index , emphasizing accessibility and treatment innovation.
Why Is UnitedHealth (NYSE:UNH) Driving S&P 500 Healthcare Sector Trends?
June 18, 2026 11:10 PM PDT| By Anmol KhazanchiManaged care leaders UnitedHealth and CVS reflect healthcare sector dynamics, with operations and demand trends benchmarked against the S&P 500 Index .
Why Is Johnson & Johnson Attracting Attention (NYSE:JNJ)
June 18, 2026 10:07 PM PDT| By Anmol KhazanchiJohnson & Johnson remains active within healthcare discussions supported by diversified operations, medical innovation, healthcare products, and global market presence.
Why Is AbbVie Attracting Attention (NYSE:ABBV)
June 18, 2026 10:05 PM PDT| By Anmol KhazanchiAbbVie remains active within healthcare discussions supported by regulatory milestones, oncology research, aesthetics expansion, and broad therapeutic expertise.
What Does Strong Shareholder Support Mean for SELLAS Life Sciences Group (NASDAQ:SLS)?
June 18, 2026 09:46 PM PDT| By Team Kalkine MediaSELLAS Life Sciences Group secured approval across all annual meeting proposals, highlighting shareholder engagement and corporate governance developments.
Spero Therapeutics Stock: Antibiotic Development In Focus
June 18, 2026 11:56 AM PDT| By Anmol KhazanchiSpero Therapeutics remains in focus as antibiotic development and regulatory progress shape infectious disease treatment discussions.
Merck Stock In Focus As Combination Therapies Shape Healthcare
June 18, 2026 11:53 AM PDT| By Anmol KhazanchiPharmaceutical innovation remains shaped by combination therapies, regulatory progress, and oncology pipeline development, keeping healthcare companies central to modern treatment advancement.
Gilead Sciences Cell Therapy Move Draws Biotech Attention
June 18, 2026 11:47 AM PDT| By Anmol KhazanchiGilead Sciences features within the healthcare stocks space as cell therapy expansion through acquisition draws attention amid a broader pickup in biotech dealmaking activity.
Protecting Young Lives: Merck Expands CAPVAXIVE Access
June 18, 2026 08:58 AM PDT| By Anmol KhazanchiMerck (NYSE:MRK) expands CAPVAXIVE eligibility through FDA approval, enhancing pneumococcal disease protection for at-risk children and adolescents while reinforcing advancements in vaccine innovation and public health.
Elanco Ventures Expands Animal Health Innovation Ecosystem
June 18, 2026 08:52 AM PDT| By Anmol KhazanchiElanco Animal Health is strengthening the future of animal care through Elanco Ventures, a new innovation-focused initiative designed to support emerging technologies and industry collaboration.
Alignment Healthcare Strengthens Its Position Following Key Business Developments
June 18, 2026 08:13 AM PDT| By Anmol KhazanchiAlignment Healthcare (NYSE:ALHC) is drawing attention after reporting stronger financial results and implementing leadership changes, highlighting operational efficiency, profitability progress, and long-term opportunities within the healthcare servi...
Aquestive Therapeutics (NYSE:AQST): What Insider Activity Reveals About Corporate Confidence
June 18, 2026 05:08 AM PDT| By Vivek SinghAn in-depth look at insider activity, ownership structure, and market sentiment surrounding Aquestive Therapeutics (NYSE:AQST), highlighting what investors can learn from recent corporate share transactions.
Why Is Life Time Group Holdings Stock Moving After Residential Project Agreement
June 17, 2026 10:28 PM PDT| By Anmol KhazanchiLife Time Group Holdings expands its wellness model into residential environments, highlighting growing integration of lifestyle services across housing, fitness, and community-focused developments.
Why Is OmniAb Gaining Attention In The Biotechnology Landscape?
June 17, 2026 09:24 PM PDT| By Anmol KhazanchiOmniAb remains active within biotechnology through antibody discovery technologies, research collaborations, and platform-based scientific innovation.
Biotech & Emerging Healthcare Stocks Add Sector Depth
June 17, 2026 11:19 AM PDT| By Anmol KhazanchiBiotech and emerging healthcare names add depth as pipelines, acquisitions, and science shape the sector.
What Keeps These Healthcare Names In Constant Focus?
June 17, 2026 11:14 AM PDT| By Anmol KhazanchiNames tied to diabetes and weight-management treatments continue to command the healthcare spotlight, with operators such as Eli Lilly featured amid intense focus on a fast-evolving therapeutic category and broader sector sentiment.
Pharma Giants Navigate A Busy Deal-Making Backdrop
June 17, 2026 11:07 AM PDT| By Anmol KhazanchiLarge pharmaceutical names are navigating a busy deal-making backdrop as the sector reshapes around pipelines and patent considerations, with companies such as Merck and Gilead featured amid an active wave of transactions.
Why Is Eli Lilly Stock Drawing Attention Across Healthcare?
June 17, 2026 08:04 AM PDT| By Anmol KhazanchiEli Lilly continues attracting attention through expanding treatment demand, strong operational performance, and a prominent position within the healthcare sector.
